Peptide and DNA vaccines that double block PD-1 and LAG3 showed a great anti-tumor effect, especially in a MycCaP prostate cancer model, which significantly increased the levels of CD8+T cells, which express more immune checkpoints, underlying the role of APCs (69). This evidence concerns the gene CD8A and neoplasm.